Advances in pharmacologic therapies for type 2 diabetes.

Current atherosclerosis reports

Volumn 15, Issue 2, 2013, Pages

  Morsink, Linde M ^a   Smits, Mark M ^b   Diamant, Michaela ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

BLOOD; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEALTH; HUMAN; METABOLISM; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REVIEW; TREATMENT OUTCOME;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; MORBIDITY; PREVALENCE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84879546835     PISSN: None     EISSN: 15346242     Source Type: None    
DOI: 10.1007/s11883-012-0302-8     Document Type: Review

References (0)